Literature DB >> 29218495

Systemic Epstein-Barr virus-positive T-cell lymphoproliferative disorders of childhood with fulminant leukocytosis and tumor lysis: a case report with autopsy findings.

Sachie Wada1, Takayuki Suzuki2, Koichi Kitazume2, Akira Fujita2, Seiichiro Shimizu3.   

Abstract

Systemic Epstein-Barr virus (EBV)-positive T-cell lymphoproliferative disorders (T-LPD) of childhood is an extremely rare disease characterized by an aggressive clinical course and very poor prognosis. We report an adolescent male with systemic EBV-positive T-LPD of childhood after primary EBV infection, resulting in a fatal clinical course within 9 days, along with autopsy findings. A 19-year-old male without an immunocompromised status presented with an acute onset of high fever, and was hospitalized for persistent fever, vomiting and diarrhea on the 5th day from onset. Laboratory data showed severe thrombocytopenia, increased ferritin level, liver dysfunction, disseminated intravascular coagulation, and anti-EBV-IgM positivity. Peripheral blood smears identified a number of atypical lymphocytes. Bone marrow aspiration revealed many atypical various-sized lymphocytes with apparent nucleoli and hemophagocytosis. Atypical lymphocytes displayed a CD8+ T-cell phenotype with monoclonal rearrangement of T-cell receptors. EBV-encoded RNA was also observed in lymphoid cells by in situ hybridization. The patient received dexamethasone and cyclosporine with no improvement, and died of tumor lysis by leukocytosis on the 9th day from onset.

Entities:  

Keywords:  Epstein–Barr virus (EBV); Fulminant; Leukocytosis; T-cell lymphoproliferative disorders (T-LPD); Tumor lysis

Mesh:

Year:  2017        PMID: 29218495     DOI: 10.1007/s12185-017-2380-4

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  8 in total

1.  Infectious mononucleosis as a disease of early childhood in Japan caused by primary Epstein-Barr virus infection.

Authors:  H Kanegane; C Kanegane; A Yachie; T Miyawaki; G Tosato
Journal:  Acta Paediatr Jpn       Date:  1997-04

2.  Blastic natural killer cell lymphoma/leukemia (CD56-positive blastic tumor): prognostication and categorization according to anatomic sites of involvement.

Authors:  Ritsuro Suzuki; Shigeo Nakamura; Junji Suzumiya; Koichi Ichimura; Masako Ichikawa; Kiyoyuki Ogata; Yoshimasa Kura; Keiko Aikawa; Hirofumi Teshima; Masahiro Sako; Hiroshi Kojima; Mitsufumi Nishio; Tadashi Yoshino; Hiroki Sugimori; Keisei Kawa; Kazuo Oshimi
Journal:  Cancer       Date:  2005-09-01       Impact factor: 6.860

Review 3.  How we treat chronic active Epstein-Barr virus infection.

Authors:  Akihisa Sawada; Masami Inoue; Keisei Kawa
Journal:  Int J Hematol       Date:  2017-02-16       Impact factor: 2.490

4.  Systemic Epstein-Barr virus positive T-cell lymphoproliferative disease of childhood with hemophagocytic syndrome.

Authors:  Guoshu Chen; Li Chen; Xiaohua Qin; Zhuoya Huang; Xiaoling Xie; Guowei Li; Bing Xu
Journal:  Int J Clin Exp Pathol       Date:  2014-09-15

5.  Systemic Epstein-Barr virus-positive T-cell lymphoproliferative disease of childhood: Report of a case with review of the literature.

Authors:  Miyuki Yoshii; Mitsuaki Ishida; Keiko Hodohara; Hiroko Okuno; Ryota Nakanishi; Takashi Yoshida; Hidetoshi Okabe
Journal:  Oncol Lett       Date:  2012-06-12       Impact factor: 2.967

6.  Fulminant EBV(+) T-cell lymphoproliferative disorder following acute/chronic EBV infection: a distinct clinicopathologic syndrome.

Authors:  L Quintanilla-Martinez; S Kumar; F Fend; E Reyes; J Teruya-Feldstein; D W Kingma; L Sorbara; M Raffeld; S E Straus; E S Jaffe
Journal:  Blood       Date:  2000-07-15       Impact factor: 22.113

7.  EBV-associated T/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases.

Authors:  Hiroshi Kimura; Yoshinori Ito; Shinji Kawabe; Kensei Gotoh; Yoshiyuki Takahashi; Seiji Kojima; Tomoki Naoe; Shinichi Esaki; Atsushi Kikuta; Akihisa Sawada; Keisei Kawa; Koichi Ohshima; Shigeo Nakamura
Journal:  Blood       Date:  2011-11-16       Impact factor: 22.113

Review 8.  Proposed categorization of pathological states of EBV-associated T/natural killer-cell lymphoproliferative disorder (LPD) in children and young adults: overlap with chronic active EBV infection and infantile fulminant EBV T-LPD.

Authors:  Koichi Ohshima; Hiroshi Kimura; Tadashi Yoshino; Chul Woo Kim; Young H Ko; Seung-Suk Lee; Suat-Cheng Peh; John K C Chan
Journal:  Pathol Int       Date:  2008-04       Impact factor: 2.534

  8 in total
  1 in total

Review 1.  When Onco-Immunotherapy Meets Cold Atmospheric Plasma: Implications on CAR-T Therapies.

Authors:  Xiaofeng Dai; Jitian Li; Yiming Chen; Kostya Ken Ostrikov
Journal:  Front Oncol       Date:  2022-02-23       Impact factor: 6.244

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.